Protein quantification or total protein content by colorimetric methods such as absorbance at 280, Bradford or BCA assays and quantitative amino acid analysis
Protein quantification is necessary to understand the total protein content in a sample or in a formulated product. Accurate protein quantification is important as a range of other critical assays require precise total protein content results in order to generate data. Careful selection of the protein quantification method is required to ensure accurate data. Colorimetric assays, for example, are dependent on the use of an external reference standard and the different absorbance properties between product and the reference standard may lead to inaccuracies. Quantitative amino acid analysis can also be used for protein content determination but an understanding of how different proteins hydrolyze under similar conditions and the stability of amino acids during hydrolysis is critical.
Our scientists are experts in the selection of protein quantification assays which is underpinned by a deep knowledge of the physicochemical properties of proteins and amino acids. We address any potential source of variability in the accuracy of measurement of total protein content, delivering precise and robust data every time.
We provide a range of total protein quantification methods, including European Pharmacopoeia (EP) and United States Pharmacopeia (USP) methods. Colorimetric assays such as the Bradford or bicinchoninic acid (BCA) assays measure UV-light absorbance and can be used to calculate protein concentration from the absorbance measurement, once the extinction coefficient (molar absorptivity) has been accurately established. Other assays include absorbance at 280nm, Lowry assay and the Biuret assay. We also provide quantitative amino acid analysis by High performance liquid chromatography (HPLC) or ion chromatography (IC).
Our experts are also adept at determining the extinction coefficient (molar absorptivity) for a protein by determining the absorbance using UV/visible spectrophotometry of a solution of known protein content as determined by quantitative amino acid analysis or total nitrogen determination.
Protein quantification can be offered from our cGMP compliant laboratories as a standalone test or as part of a biologic release testing package for commercial release or a biopharmaceutical stability study test.
As your outsourcing partner for biologics or protein product development, our expertise in protein content can accelerate development timelines through delivering accurate and robust analytical services. Bringing quality and safety to life, we offer Total Quality Assurance expertise to help you to meet and exceed quality, safety and regulatory standards.
COVID-19 VACCINE OR THERAPEUTIC TESTING & DEVELOPMENT SUPPORT
IMMEDIATE QUESTION? Ask our experts now
FACTSHEET: COVID-19 Vaccine or Therapeutic Testing & Development Outsourcing
ARTICLE: Repurposing Vaccines for Intranasal Development
WEBINAR: Quality Control Strategy for Vaccine Development
WEBINAR: Repurposing Drugs for Inhaled Delivery
eBOOK: Contingency Outsourcing Solutions
NEW! Discover our Audit Live Tool for direct access to our scheduled audits
EVENT: 2nd Annual Inhaled and Nasal Biologics/DNA Forum - REGISTRATION IS LIVE
VIDEO:EXTRACTABLES/LEACHABLES LAB TOUR - Request access
WORKSHOP: How to Build an Inhaler (RDD 2023)
PRESENTATION:E&L Strategies (3rd Annual Extractables & Leachables Conference)
TALK: Medical Device Extractables & Leachables Studies
TALK: ID and sensitivity issues during E&L studies
ARTICLE: Glycosylation Analytical Approaches for Antibody Therapeutics
APP NOTE: Rapid Determination of Low/Trace Level Benzene in Pharmaceutical Excipients and Finished Products
ARTICLE: Importance of Aligning a Pharma Audit Scope with the Correct Standard
TALK: mRNA Analytics: Capping Efficiency, Sequencing, Poly-A Tail, dsRNA
New Approaches to Bioassay Design
Characterisation of Bispecifics
The Significance and Challenges of Inhaled and Nasal Biologics
Monoclonal Antibody Characterisation - Addressing CQAs
Current Analytical Approaches to Biophysical Characterisation
Biosimilar Characterisation and Immunogenicity
GMP Flow Cytometry: Applications, Considerations and Challenges
Liposome Physicochemical Property Analysis
Formulation of Biologics for Inhaled and Nasal Delivery
The Complexities of Antibody Drug Conjugate Characterization
Download: Intertek Biopharmaceutical Services Brochure
Download: Intertek Pharmaceutical Services